Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Patients With Early-stage Invasive Breast Cancer and Breast-conserving Surgery: a Randomized Prospective Surgical Trial. Intergroup-Sentinel-Mamma (INSEMA)-Trial

NCT02466737 is registered in ClinicalTrials.gov with University of Rostock as lead sponsor.

NCT NCT02466737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02466737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Patients With Early-stage Invasive Breast Cancer and Breast-conserving Surgery: a Randomized Prospective Surgical Trial. Intergroup-Sentinel-Mamma (INSEMA)-Trial
Lead sponsor
University of Rostock
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2015
Completion date
December 31, 2029
Enrollment
5,505 (actual)
Sites
150

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer